The purpose of the study is to determine the one-year post stenting outcomes in patients who were treated with the Wingspan stent on-label in the WEAVE trial. This includes both the assessment of any stroke, hemorrhage, or death, as well as assessment of delayed imaging results to determine the re-stenosis rate of the stents in these patients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
1-year stroke rate following placement of Wingspan stent in this patient cohort
Timeframe: 1 year
1-year death rate following placement of Wingspan stent in this patient cohort
Timeframe: 1 year